litlas
ログインアカウント作成

Wells A. Messersmith

1997–2025 年に発表

107
論文数
19,499
被引用数
68
h 指数
100
i10 指数

被引用数

Wells A. Messersmith の年別被引用数1990 年: 被引用 1 件1993 年: 被引用 1 件1998 年: 被引用 3 件1999 年: 被引用 8 件2000 年: 被引用 2 件2001 年: 被引用 2 件2002 年: 被引用 1 件2004 年: 被引用 3 件2005 年: 被引用 5 件2006 年: 被引用 6 件2007 年: 被引用 6 件2008 年: 被引用 19 件2009 年: 被引用 59 件2010 年: 被引用 63 件2011 年: 被引用 68 件2012 年: 被引用 75 件2013 年: 被引用 137 件2014 年: 被引用 138 件2015 年: 被引用 138 件2016 年: 被引用 132 件2017 年: 被引用 182 件2018 年: 被引用 189 件2019 年: 被引用 722 件2020 年: 被引用 786 件2021 年: 被引用 888 件2022 年: 被引用 744 件2023 年: 被引用 703 件2024 年: 被引用 1,034 件2025 年: 被引用 555 件2026 年: 被引用 13 件1991〜1992 年は被引用が無いため表示していません1994〜1997 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,403 件、この内訳の 26%中国: 引用元論文 1,701 件、この内訳の 18.4%イタリア: 引用元論文 549 件、この内訳の 5.9%イギリス: 引用元論文 405 件、この内訳の 4.4%ドイツ: 引用元論文 378 件、この内訳の 4.1%スペイン: 引用元論文 328 件、この内訳の 3.5%フランス: 引用元論文 305 件、この内訳の 3.3%日本: 引用元論文 301 件、この内訳の 3.3%オランダ: 引用元論文 243 件、この内訳の 2.6%カナダ: 引用元論文 236 件、この内訳の 2.6%韓国: 引用元論文 210 件、この内訳の 2.3%オーストラリア: 引用元論文 209 件、この内訳の 2.3%
0%26%その他 21.3%

機関

分野

  • Medicine61.9%
  • Biochemistry, Genetics and Molecular Biology26.4%
  • Immunology and Microbiology6.6%
  • Engineering1.7%
  • Computer Science0.9%
  • Materials Science0.6%
  • その他1.9%

トピック

  • Colorectal Cancer Treatments and Studies4.6%
  • Colorectal Cancer Surgical Treatments4.3%
  • Cancer Cells and Metastasis3.4%
  • Cancer Genomics and Diagnostics3.1%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Genetic factors in colorectal cancer2.5%
  • その他79.2%

共著者

全論文

検索で開く
  1. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Linda M. Farkas, Ignacio Garrido‐Laguna, Jean L. Grem, Andrew J. Gunn, J. Randolph Hecht, Sarah E. Hoffe, Joleen M. Hubbard, Steven R. Hunt, Kimberly L. Johung, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Michael J. Overman, Aparna R. Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2021 被引用: 1,748

  2. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Nilofer Azad, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido‐Laguna, Jean L. Grem, Andrew J. Gunn, J. Randolph Hecht, Sarah E. Hoffe, Joleen M. Hubbard, Steven R. Hunt, William R. Jeck, Kimberly L. Johung, Natalie Kirilcuk, Smitha Krishnamurthi, Jennifer K. Maratt, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Michael J. Overman, Aparna Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Eden Stotsky‐Himelfarb, Anna Tavakkoli, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2022 被引用: 819

  3. Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

    著者: Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi, Wells A. Messersmith, Robert H.I. Andtbacka, Matthew Ingham, Nancy Lewis, Xinhui Chen, Marc R. Pelletier, Xueying Chen, Jincheng Wu, Thomas W. Dubensky, Sarah M. McWhirter, Thomas Müller, Nitya Nair, Jason J. Luke - Clinical Cancer Research 2021 被引用: 362

  4. Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

    著者: Aditya Bardia, Wells A. Messersmith, Ebenezer A. Kio, Jordan Berlin, Linda T. Vahdat, Gregory A. Masters, R Moroose, Alessandro D. Santin, Kevin Kalinsky, Vincent J. Picozzi, Joyce O’Shaughnessy, Jhanelle E. Gray, Takefumi Komiya, Joshua M. Lang, Jenny C. Chang, Alexander Starodub, David M. Goldenberg, Robert M. Sharkey, Pius Maliakal, Q. Hong, William A. Wegener, Trishna Goswami, Allyson J. Ocean - Annals of Oncology 2021 被引用: 375

  5. Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

    著者: Aditya Bardia, Ingrid A. Mayer, Jennifer R. Diamond, Rebecca Moroose, Steven J. Isakoff, Alexander Starodub, Nikita Shah, Joyce O’Shaughnessy, Kevin Kalinsky, Michael J. Guarino, Vandana G. Abramson, Dejan Juric, Sara M. Tolaney, Jordan Berlin, Wells A. Messersmith, Allyson J. Ocean, William A. Wegener, Pius Maliakal, Robert M. Sharkey, Serengulam V. Govindan, David M. Goldenberg, Linda T. Vahdat - Journal of Clinical Oncology 2017 被引用: 409

  6. Patient-derived tumour xenografts as models for oncology drug development

    著者: John J. Tentler, Aik Choon Tan, Colin D. Weekes, Antonio Jimeno, Stephen Leong, Todd M. Pitts, John J. Arcaroli, Wells A. Messersmith, Sabine Eckhardt - Nature Reviews Clinical Oncology 2012 被引用: 1,297

  7. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Paul F. Engstrom, Jean L. Grem, Axel Grothey, Howard S. Höchster, Sarah E. Hoffe, Steven R. Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey A. Meyerhardt, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard B. Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Lisa Gurski, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 被引用: 994

  8. Sacituzumab govitecan (IMMU‐132), an anti‐Trop‐2‐SN‐38 antibody‐drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics

    著者: Allyson J. Ocean, Alexander Starodub, Aditya Bardia, Linda T. Vahdat, Steven J. Isakoff, Michael J. Guarino, Wells A. Messersmith, Vincent J. Picozzi, Ingrid A. Mayer, William A. Wegener, Pius Maliakal, Serengulam V. Govindan, Robert M. Sharkey, David M. Goldenberg - Cancer 2017 被引用: 236

  9. NCCN Guidelines Insights: Colon Cancer, Version 2.2018

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Paul F. Engstrom, Ignacio Garrido‐Laguna, Jean L. Grem, Axel Grothey, Howard S. Höchster, Sarah E. Hoffe, Steven R. Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard B. Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 被引用: 1,029

  10. Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study

    著者: Nehal J. Lakhani, Laura Q.M. Chow, Justin F. Gainor, Patricia LoRusso, Keun‐Wook Lee, Hyun Cheol Chung, Jeeyun Lee, Yung‐Jue Bang, F. Stephen Hodi, Won Seog Kim, Rafael Santana-Dávila, Philip Fanning, Pierre Squifflet, Feng Jin, Tracy C. Kuo, Hong Wan, Jaume Pons, Sophia Randolph, Wells A. Messersmith - The Lancet Oncology 2021 被引用: 127

  11. Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer

    著者: Christopher H. Lieu, Erica A. Golemis, Ilya G. Serebriiskii, Justin Y. Newberg, Amanda Hemmerich, Caitlin Connelly, Wells A. Messersmith, Cathy Eng, S. Gail Eckhardt, Garrett M. Frampton, Matthew Cooke, Joshua E. Meyer - Clinical Cancer Research 2019 被引用: 250

  12. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Mohamed A. Adam, George J. Chang, Yi-Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido‐Laguna, Jean L. Grem, Paul Haste, J. Randolph Hecht, Sarah E. Hoffe, Steven R. Hunt, Hisham Hussan, Kimberly L. Johung, Nora Joseph, Natalie Kirilcuk, Smitha Krishnamurthi, Midhun Malla, Jennifer K. Maratt, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Michael J. Overman, Aparna Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, Benjamin D. Shogan, John M. Skibber, Constantinos T. Sofocleous, Anna Tavakkoli, Christopher G. Willett, Christina Wu, Lisa A. Gurski, Jenna Snedeker, Frankie Jones - Journal of the National Comprehensive Cancer Network 2024 被引用: 308

  13. Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer

    著者: Ryan B. Corcoran, Chloé E. Atreya, Gerald S. Falchook, Eunice L. Kwak, David P. Ryan, Johanna C. Bendell, Omid Hamid, Wells A. Messersmith, Adil Daud, Razelle Kurzrock, Mariaelena Pierobon, Peng Sun, Elizabeth Cunningham, Shonda M Little, Keith Orford, Monica Motwani, Yuchen Bai, Kiran Klaus Patel, Alan P. Venook, Scott Kopetz - Journal of Clinical Oncology 2015 被引用: 512

  14. Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?

    著者: Robert W. Lentz, Meryl D. Colton, Siddhartha S. Mitra, Wells A. Messersmith - Molecular Cancer Therapeutics 2021 被引用: 112

  15. NCCN Guidelines Insights: Rectal Cancer, Version 6.2020

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido‐Laguna, Jean L. Grem, Andrew J. Gunn, Sarah E. Hoffe, Joleen M. Hubbard, Steven R. Hunt, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Michael J. Overman, Aparna R. Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Alyse Johnson-Chilla, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2020 被引用: 500

  16. A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors

    著者: Antonio Jimeno, Michael A. Gordon, Rashmi Chugh, Wells A. Messersmith, David S. Mendelson, Jakob Dupont, Robert Stagg, Ann M. Kapoun, Lu Xu, Shailaja Uttamsingh, Rainer K. Brachmann, David C. Smith - Clinical Cancer Research 2017 被引用: 204

  17. Therapy of Advanced Non–Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan

    著者: Rebecca S. Heist, Michael J. Guarino, Gregory A. Masters, W. Thomas Purcell, Alexander Starodub, Leora Horn, Ronald Scheff, Aditya Bardia, Wells A. Messersmith, Jordan Berlin, Allyson J. Ocean, Serengulam V. Govindan, Pius Maliakal, Boyd Mudenda, William A. Wegener, Robert M. Sharkey, David M. Goldenberg, D. Ross Camidge - Journal of Clinical Oncology 2017 被引用: 190

  18. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Lynette Cederquist, Emily Chan, Yi‐Jen Chen, Harry S. Cooper, Dustin A. Deming, Paul F. Engstrom, Peter C. Enzinger, Alessandro Fichera, Jean L. Grem, Axel Grothey, Howard S. Höchster, Sarah E. Hoffe, Steven R. Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard B. Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Christina Wu, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2017 被引用: 1,371

  19. NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024

    著者: Al B. Benson, Alan P. Venook, Mohamed A. Adam, George J. Chang, Yi-Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido‐Laguna, Jean L. Grem, Paul Haste, J. Randolph Hecht, Sarah E. Hoffe, Steven R. Hunt, Hisham Hussan, Kimberly L. Johung, Nora Joseph, Natalie Kirilcuk, Smitha Krishnamurthi, Midhun Malla, Jennifer K. Maratt, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Aparna Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, Benjamin D. Shogan, John M. Skibber, Constantinos T. Sofocleous, Anna Tavakkoli, Christopher G. Willett, Christina Wu, Frankie Jones, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2024 被引用: 215

  20. Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer

    著者: Efrat Dotan, Dana B. Cardin, Heinz‐Josef Lenz, Wells A. Messersmith, Bert H. O’Neil, Steven J. Cohen, Crystal S. Denlinger, Safi Shahda, Igor Astsaturov, Ann M. Kapoun, Rainer K. Brachmann, Shailaja Uttamsingh, Robert Stagg, Colin D. Weekes - Clinical Cancer Research 2020 被引用: 70

  21. Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial

    著者: Jeffrey R. Infante, Leslie A. Fecher, Gerald S. Falchook, Sujatha Nallapareddy, Michael S. Gordon, Carlos Becerra, Douglas J. DeMarini, Donna S. Cox, Yanmei Xu, Shannon R. Morris, Vijay Peddareddigari, Ngocdiep T. Le, Lowell L. Hart, Johanna C. Bendell, Gail Eckhardt, Razelle Kurzrock, Keith T. Flaherty, Howard A. Burris, Wells A. Messersmith - The Lancet Oncology 2012 被引用: 558

  22. Advances in the management of pancreatic cancer

    著者: Marco Del Chiaro, Toshitaka Sugawara, Sana D. Karam, Wells A. Messersmith - BMJ 2023 被引用: 102

  23. Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

    著者: Jhanelle E. Gray, Rebecca S. Heist, Alexander Starodub, D. Ross Camidge, Ebenezer A. Kio, Gregory A. Masters, W. Thomas Purcell, Michael J. Guarino, Jamal Misleh, Charles Schneider, Bryan J. Schneider, Allyson J. Ocean, Tirrell Johnson, Leena Gandhi, Kevin Kalinsky, Ronald Scheff, Wells A. Messersmith, Serengulam V. Govindan, Pius Maliakal, Boyd Mudenda, William A. Wegener, Robert M. Sharkey, David M. Goldenberg - Clinical Cancer Research 2017 被引用: 159

  24. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

    著者: Adam C. Mueller, Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia, Andy V. Phan, Benjamin Van Court, Kathryn L. Zolman, Brisa Peña, Ayman Oweida, Sara Zakem, Cheryl Meguid, Michael W. Knitz, Laurel B. Darragh, Thomas E. Bickett, Jacob Gadwa, Luisa Mestroni, Matthew R.G. Taylor, Kimberly R. Jordan, Peter J. Dempsey, M. Scott Lucia, Martin D. McCarter, Marco Del Chiaro, Wells A. Messersmith, Richard D. Schulick, Karyn A. Goodman, Michael J. Gough, Casey S. Greene, James C. Costello, Antonio Galveo Neto, David Lagares, Kirk C. Hansen, Adrie van Bokhoven, Sana D. Karam - Cancer Research 2021 被引用: 69